The four Technion projects are:<\/span><\/p>\n The 16 winning research proposals in the current round were selected from 75 submitted proposals on a wide range of topics related to human biology as it applies to medicine. This program enables further expansion and deepening of personalized medicine in Israel. The winning bids were selected in a competitive process, based on scientific excellence, by an international judging committee chaired by the Nobel laureate for Chemistry, Professor Roger Kornberg of Stanford University.\u00a0<\/span><\/p>\n Research in the field of Precision Medicine is based on broad interdisciplinary collaborations that integrate scientific and medical knowledge, theory, in-depth analysis of medical big data, and extensive experimental work. The research program is based on a pooling of resources, which is part of the Planning and Budgeting Committee of the Council for Higher Education, the Ministry of Health, Israel’s digital project of the Ministry of Social Equality, the Yad Hanadiv and the Kellerman Family Foundation (Boston). The program is run and operated by the National Science Foundation (ISF). Professor Yuval Dor, Head of ISF\u2019s Life Sciences and Medicine division<\/b>: \u201cIn IPMP\u2019s second program cycle, we have witnessed a wealth of outstanding research programs that reflect the scientific depth and spirit of collaboration among researchers and physicians in Israel, and among universities, hospitals, and health funds. We were pleased to have been able to conduct the competitive evaluation process without delay, despite disruptions caused by the coronavirus pandemic. The winning proposals are from a range of universities and medical institutions, address fundamental questions in human health, and are expected to generate important scientific insights and medical applications.\u201d<\/span><\/p>\n Professor Yaffa Zilbershats, Chair of the Council for Higher Education\u2019s Planning and Budgeting Committee<\/b>: \u201cThe IPMP program is a source of pride and satisfaction. By the end of the first cycle, it emerged that the program had exceeded all expectations. The second cycle reinforces this understanding. I am excited to see the content of the winning projects, their scientific quality, and the collaborations between scientists from academia and physicians and researchers from health organizations. There is no doubt that the program will make a huge contribution to advancing research and medicine in Israel and around the world. I thank the members of the Israel Science Foundation (ISF), who rose up to the challenge of evaluating the proposals within the timetables, despite the coronavirus outbreak.\u201d<\/span><\/p>\n Shai-Lee Spigelman, CEO, Digital Israel, Ministry of Social Equality: <\/b>\u201cThe IPMP program is a significant part of the Digital Health initiative as an engine of growth, positioning Israel at the forefront of the digital health revolution. It demonstrates the tremendous value of the medical information generated in Israel. The outstanding research studies that won the second cycle of the program will expand our understanding of a variety of diseases and help prevent and treat them. Equally important, they will strengthen the excellent existing collaboration between Israel\u2019s academia and health system. This collaboration underpins Israel\u2019s excellence in health and is one of the reasons for Israel\u2019s success in battling the first wave of the coronavirus pandemic.\u201d<\/span><\/p>\n\n
\n
\n
\n
![\"\"](\"https:\/\/www.technion.ac.il\/wp-content\/uploads\/2020\/05\/\u05e7\u05d5\u05dc\u05d0\u05d6-\u05e4\u05d5\u05e1\u05d8-270520-1-1024x1024.jpg\")
<\/span><\/p>\n